Join the Herpes Zoster - Prophylaxis group to help and get support from people like you.
Herpes Zoster - Prophylaxis News
Related terms: Shingles, Prophylaxis
Florida Plans to End All Vaccine Mandates
THURSDAY, Sept. 4, 2025 — Florida may soon become the first state in the U.S. to eliminate all vaccine mandates, a major shift in health policy that may increase risk of disease outbreaks. The plan w...
Shingles Vaccine, Shingrix, Might Protect Against Heart Attack, Stroke
FRIDAY, Aug. 29, 2025 — The shingles vaccine not only protects against the painful skin infection, but also might provide heart health benefits, a new study says. Shingles vaccination also appears to ...
US FDA Approves GSK’s Shingrix in a Prefilled Syringe Presentation
London, UK 17 July 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster ...
FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
MONDAY, July 21, 2025 – The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles...
Live Zoster Vaccination Linked to Lower Risk for Cardiovascular Events
THURSDAY, May 8, 2025 – Live zoster vaccination is associated with a lower risk for overall cardiovascular events when compared with no vaccination, according to a study published online May 5 in...
Zoster Vaccine Has Dementia-Preventing or Delaying Effect
THURSDAY, April 3, 2025 – Zoster vaccination seems to have a dementia-preventing or dementia-delaying effect, according to a study published online April 2 in Nature. Markus Eyting, Ph.D., from...
Everything You Need to Know About Shingles & the Shingles Vaccine
SUNDAY, Dec. 8, 2024 – Shingles can strike anyone who had chickenpox when they were young, and the intense pain that can accompany this body rash has sidelined many a senior. Here, one expert...
Shingrix Approved in the US for Prevention of Shingles in Immunocompromised Adults
Philadelphia, London – 26 July 2021 – GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the...